The DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index.
Identification of integrin αMβ2 as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions
Abstract
Cysteine-rich 61 (Cyr61, CCN1) and connective tissue growth factor (CTGF, CCN2) are growth factor–inducible immediate-early gene products found in blood vessel walls and healing cutaneous wounds. We previously reported that the adhesion of endothelial cells, platelets, and fibroblasts to these extracellular matrix–associated proteins is mediated through integrin receptors. In this study, we demonstrated that both Cyr61 and CTGF are expressed in advanced atherosclerotic lesions of apolipoprotein E–deficient mice. Because monocyte adhesion and transmigration are important for atherosclerosis, wound healing, and inflammation, we examined the interaction of THP-1 monocytic cells and isolated peripheral blood monocytes with Cyr61 and CTGF. THP-1 cells and monocytes adhered to Cyr61- or CTGF-coated wells in an activation-dependent manner and this process was mediated primarily through integrin αMβ2. Additionally, expression of αMβ2 on human embryonic kidney 293 cells resulted in enhanced cell adhesion to Cyr61. Consistent with these data, a GST-fusion protein containing the I domain of the integrin αM subunit bound specifically to immobilized Cyr61 or CTGF. We have also investigated the requirement of cell surface heparan sulfate proteoglycans (HSPGs) as coreceptors for monocyte adhesion to Cyr61. Pretreatment of monocytes with heparin or heparinase I resulted in partial inhibition of cell adhesion to Cyr61. However, monocytes, but not fibroblasts, were capable of adhering to a Cyr61 mutant deficient in heparin binding activity. Collectively, these results show that activated monocytes adhere to Cyr61 and CTGF through integrin αMβ2 and cell surface HSPGs. However, unlike fibroblast adhesion to Cyr61, cell surface HSPGs are not absolutely required for this adhesion process.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Subsequent studies have shown that CCN1 supports cell adhesion by binding integrins α6β1 and HSPGs in fibroblasts and smooth muscle cells [55,56], αIIbβ3 in activated platelets [57], αMβ2 in monocytes and macrophages [58,59], and αDβ2 in macrophage foam cells [60].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [58]
In the citing paper
“Furthermore, CCN1 supports the adhesion of activated monocytes through integrin αMβ2, and reprograms macrophages towards M1 polarization through αMβ2-mediated activation of NF-κB [58,59].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [58]
In the citing paper
“CCN1 is overexpressed in vascular smooth muscle cells of atherosclerotic lesions and in the neointima of restenosis after balloon angioplasty, both in rodent models and in humans [23,56,58,135].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [58]
In the citing paper
“Furthermore, CCN1 supports the adhesion of activated monocytes through integrin αMβ2, and reprograms macrophages towards M1 polarization through αMβ2-mediated activation of NF-κB [58,59].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [58]
Citations
Cites
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.133 · Cited by 1,693
Plow, E. F., Haas, T. A., Zhang, L., Loftus, J. C., & Smith, J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000003200 · Cited by 1,359
Crystal structure of the A domain from the a subunit of integrin CR3 (CD11 b/CD18)
Lee, J., Rieu, P., Arnaout, M. A., & Liddington, R. (1995) · Cell · doi:10.1016/0092-8674(95)90517-0 · Cited by 888
Igarashi, A., Okochi, H., Bradham, D. M., & Grotendorst, G. R. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.6.637 · Cited by 699
The CCN Family of Angiogenic Regulators: The Integrin Connection
Lau, L. F., & Lam, S. C.-T. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4456 · Cited by 645
Self-citationAtherosclerosis in mice lacking apo E. Evaluation of lesional development and progression
Reddick, R. L., Zhang, S. H., & Maeda, N. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.141 · Cited by 633
The Connective Tissue Growth Factor/Cysteine- Rich 61/Nephroblastoma Overexpressed (CCN) Family
Brigstock, D. R. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.2.0360 · Cited by 588
Expression of connective tissue growth factor in human renal fibrosis
Ito, Y., Aten, J., Bende, R. J., Oemar, B. S., Rabelink, T. J., Weening, J. J., & Goldschmeding, R. (1998) · Kidney International · doi:10.1111/j.1523-1755.1998.00820.x · Cited by 558
Cited by
Sorted by citations
Items 101–200 of 243
Rother, M., Krohn, S., Kania, G., Vanhoutte, D., Eisenreich, A., Wang, X., Westermann, D., Savvatis, K., Dannemann, N., Skurk, C., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.945261 · Cited by 53
Martin-Padura, I., de Nigris, F., Migliaccio, E., Mansueto, G., Minardi, S., Rienzo, M., Lerman, L. O., Stendardo, M., Giorgio, M., De Rosa, G., et al. (2008) · Endothelium · doi:10.1080/10623320802487791 · Cited by 52
Lin, B.-R., Chang, C.-C., Chen, L.-R., Wu, M.-H., Wang, M.-Y., Kuo, I.-H., Chu, C.-Y., Chang, K.-J., Lee, P.-H., Chen, W.-J., et al. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0289 · Cited by 51
New strategy to control cell migration and metastasis regulated by CCN2/CTGF
Aguiar, D. P., de Farias, G. C., de Sousa, E. B., Coelho‐Aguiar, J. D. M., Lobo, J. C., Casado, P. L., Duarte, M. E. L., & Abreu, J. G. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-61 · Cited by 53
Liu, H., Yang, R., Tinner, B., Choudhry, A., Schütze, N., & Chaqour, B. (2008) · Endocrinology · doi:10.1210/en.2007-1415 · Cited by 50
Sakamoto, S., Yokoyama, M., Zhang, X., Kulkarni, P., Nagao, K., Hatanaka, T., Getzenberg, R. H., & Kakehi, Y. (2004) · Endocrinology · doi:10.1210/en.2003-1350 · Cited by 52
Lee, Y., Hong, C., Kok, S., Hou, K., Lin, Y.-T., Chen, M.-H., Wang, C.-C., & Lin, S. (2009) · Journal of Endodontics · doi:10.1016/j.joen.2008.11.015 · Cited by 50
Zaykov, V., & Chaqour, B. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00650-2 · Cited by 48
The role of the CCN family of proteins in female reproduction
Winterhager, E., & Gellhaus, A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1556-9 · Cited by 52
Ball, D., Moussad, E. E.-D. A., Rageh, M. A. E., Kemper, S., & Brigstock, D. R. (2003) · Reproduction · doi:10.1530/rep.0.1250271 · Cited by 48
Mason, R. M. (2012) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2012.00845.x · Cited by 47
Connective tissue growth factor and renal diseases: some answers, more questions
Wahab, N. A., & Mason, R. M. (2003) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200401000-00008 · Cited by 46
Connective tissue growth factor (CCN2) in blood vessels
Ponticos, M. (2013) · Vascular Pharmacology · doi:10.1016/j.vph.2013.01.004 · Cited by 44
You, J.-J., Yang, C., Yang, C., & Chen, M. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.026 · Cited by 46
Ugarova, T. P., Moreno, B., Podolnikova, N. P., & Lishko, V. K. (2016) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s107070 · Cited by 44
Self-citationThorne, A. H., Meisen, W. H., Russell, L., Yoo, J. Y., Bolyard, C. M., Lathia, J. D., Rich, J. N., Puduvalli, V. K., Mao, H. C., Yu, J., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.101 · Cited by 43
G Protein-Coupled Receptors Go Extracellular: RhoA Integrates the Integrins
Walsh, C. T., Stupack, D., & Brown, J. H. (2008) · Molecular Interventions · doi:10.1124/mi.8.4.8 · Cited by 40
Shen, D., Podolnikova, N. P., Yakubenko, V. P., Ardell, C. L., Balabiyev, A., Ugarova, T. P., & Wang, X. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.773713 · Cited by 41
Self-citationExpression, purification, and functional testing of recombinant CYR61/CCN1
Schütze, N., Kunzi‐Rapp, K., Wagemanns, R., Nöth, U. A., Jatzke, S., & Jakob, F. J. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2005.03.031 · Cited by 42
A turbulent path to plaque formation
Mehta, V., & Tzima, E. (2016) · Nature · doi:10.1038/nature20489 · Cited by 40
More Than Just a Removal Service: Scavenger Receptors in Leukocyte Trafficking
Patten, D. A., & Shetty, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02904 · Cited by 41
Koumarianou, A. A., Alexandraki, K., Wallin, G., Kaltsas, G., & Daskalakis, K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061777 · Cited by 39
Expression of Heregulin in Human Coronary Atherosclerotic Lesions
Panutsopulos, D., Arvanitis, D. L., Tsatsanis, C., Papalambros, E. L., Sigala, F., & Spandidos, D. A. (2005) · Journal of Vascular Research · doi:10.1159/000088100 · Cited by 39
Liu, B., Zhang, J., Zhang, X., Wu, G., & Li, M.-X. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.05.029 · Cited by 38
Zen, K., Liu, D., Li, L., Chen, C. X.-J., Guo, Y.-L., Ha, B., Chen, X., Zhang, C., & Liu, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807805200 · Cited by 38
Proteolysis of CCN1 by Plasmin: Functional Implications
Pendurthi, U. R., Tran, T. T., Post, M., & Rao, L. V. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0982 · Cited by 38
Chaqour, B. (2019) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-019-00529-3 · Cited by 38
Whitson, R. J., Lucia, M. S., & Lambert, J. R. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24484 · Cited by 37
Jiang, R., Tang, J., Zhang, X., He, Y., Yu, Z., Chen, S., Xia, J., Lin, J., & Ou, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.810671 · Cited by 36
Droppelmann, C. A., Gutiérrez, J., Vial, C., & Brandan, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807352200 · Cited by 36
An early history of CCN2/CTGF research: the road to CCN2 via hcs24, ctgf, ecogenin, and regenerin
Takigawa, M. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0414-6 · Cited by 34
Pi, L., Fu, C., Lu, Y., Zhou, J., Jorgensen, M., Shenoy, V., Lipson, K. E., Scott, E. W., & Bryant, A. J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00138 · Cited by 34
Shi, J., Huo, R., Li, N., Li, H., Zhai, T., Li, H., Shen, B., Ye, J., Fu, R., & Di, W. J. (2019) · BMC Cancer · doi:10.1186/s12885-019-6321-x · Cited by 35
Liu, D.-Q., Li, L.-M., Guo, Y.-L., Bai, R., Wang, C., Bian, Z., Zhang, C.-Y., & Zen, K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003291 · Cited by 34
Yan, L., & Chaqour, B. (2013) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-013-0206-6 · Cited by 35
Sakamoto, S., Yokoyama, M., Aoki, M., Suzuki, K., Kakehi, Y., & Saito, Y. (2004) · The Prostate · doi:10.1002/pros.20098 · Cited by 33
Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis
Mooring, M., Yeung, G. A., Luukkonen, P., Liu, S., Akbar, M. W., Zhang, G. J., Balogun, O., Yu, X., Mo, R., Nejak-Bowen, K., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade3157 · Cited by 33
Yang, R., Chen, Y., & Chen, D. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7880 · Cited by 34
Seher, A., Nickel, J., Mueller, T. D., Kneitz, S., Gebhardt, S., Meyer‐ter‐Vehn, T., Schlunck, G., & Sebald, W. (2011) · Europe PMC (PubMed Central) · Cited by 32
Toda, N., Mori, K., Kasahara, M., Ishii, A., Koga, K., Ohno, S., Mori, K. P., Kato, Y. H., Osaki, K., Kuwabara, T., et al. (2017) · Scientific Reports · doi:10.1038/srep42114 · Cited by 31
Labrousse-Arias, D., Martı́nez-Ruiz, A., & Calzada, M. J. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7275 · Cited by 30
Sigala, F., Georgopoulos, S., Papalambros, E., Chasiotis, D., Vourliotakis, G., Niforou, A., Kotsinas, A., Kavantzas, N., Patsouris, E., Gorgoulis, V. G., et al. (2006) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2006.01.026 · Cited by 30
Kok, S., Hou, K., Hong, C., Wang, J., Liang, P., Chang, C., Hsiao, M., Yang, H., Lai, E. H., & Lin, S. (2011) · Arthritis & Rheumatism · doi:10.1002/art.27433 · Cited by 30
Huang, G., & Brigstock, D. R. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01072.x · Cited by 30
Tissue Factor in Cardiovascular Disease
Holy, E. W., & Tanner, F. C. (2010) · Advances in pharmacology · doi:10.1016/s1054-3589(10)59009-4 · Cited by 31
Sohn, M., Tan, Y., Wang, B., Klein, R. L., Trojanowska, M. E., & Jaffa, A. A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01233.2004 · Cited by 29
Tsikitis, V. L., Morin, N. A., Harrington, E. O., Albina, J. E., & Reichner, J. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1284 · Cited by 29
CCN3 Regulates Macrophage Foam Cell Formation and Atherosclerosis
Shi, H., Zhang, C., Pasupuleti, V., Hu, X., Prosdocimo, D. A., Wu, W., Qing, Y., Wu, S., Mohammad, H., Gerson, S. L., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.01.020 · Cited by 28
Zhou, J., Sun, C., Yang, L., Wang, J., Jn‐Simon, N., Zhou, C., Bryant, A. J., Cao, Q., Li, C., Petersen, B. E., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101686r · Cited by 27
Delayed wound healing in Mac‐1–deficient mice is associated with normal monocyte recruitment
Sisco, M., Chao, J. D., Kim, I., Mogford, J. E., Mayadas, T. N., & Mustoe, T. A. (2007) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00264.x · Cited by 28
Emre, Y., Irla, M., Dunand-Sauthier, I., Ballet, R., Meguenani, M., Jemelin, S., Vesin, C., Reith, W., & Imhof, B. A. (2013) · Nature Communications · doi:10.1038/ncomms3842 · Cited by 27
The role of connective tissue growth factor in skeletal growth and development.
Kanaan, R. A., Aldwaik, M., & Al-Hanbali, O. A. (2006) · PubMed · Cited by 27
Emerging roles of CCN proteins in vascular development and pathology
Klenotic, P. A., Zhang, C., & Lin, Z. (2016) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-016-0332-z · Cited by 27
Liu, J., Ren, Y., Kang, L., & Zhang, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094912 · Cited by 26
Podolnikova, N. P., Hlaváčková, M., Wu, Y., Yakubenko, V. P., Faust, J. J., Balabiyev, A., Wang, X., & Ugarova, T. P. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006314 · Cited by 26
Self-citationBär, A., Dorfman, S. E., Fischer, P., Hilfiker‐Kleiner, D., Cebotari, S., Tudorache, I., Suprunov, M., Haverich, A., & Hilfiker, A. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp370 · Cited by 25
CCN family member 1 deregulates cholesterol metabolism and aggravates atherosclerosis
Zhao, J., Chen, H., Wei, J., Leu, S. J., & Lee, T. (2018) · Acta Physiologica · doi:10.1111/apha.13209 · Cited by 27
Kubota, S., Kawaki, H., Kondo, S., Yosimichi, G., Minato, M., Nishida, T., Hanagata, H., Miyauchi, A., & Takigawa, M. (2006) · Biochimie · doi:10.1016/j.biochi.2006.07.007 · Cited by 25
Matricellular proteins in atherosclerosis development
Pervaiz, N., Kathuria, I., Aithabathula, R. V., & Singla, B. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.04.003 · Cited by 25
Leguit, R. J., Raymakers, R. A. P., Hebeda, K. M., & Goldschmeding, R. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-020-00602-2 · Cited by 23
Li, S., Xu, Z., Wang, Y., Chen, L., Wang, X., Zhou, Y., Lei, D., Zang, G., & Wang, G. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.06.016 · Cited by 25
Gerritsen, K. G. F., Falke, L. L., van Vuuren, S. H., Leeuwis, J. W., Broekhuizen, R., Nguyen, T. Q., de Borst, G. J., Nathoe, H. M., Verhaar, M. C., Kok, R. J., et al. (2016) · Growth Factors · doi:10.1080/08977194.2016.1210142 · Cited by 23
Li, T., Qian, Y., Li, H., Wang, T., Jiang, Q., Wang, Y., Zhu, Y., Li, S., He, X., Shi, G., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01653-3 · Cited by 22
Liu, L., Shi, H., Jiang, L., Wang, L., Ma, S., Dong, C., Wang, J., Zhao, H., Liao, Y., & Li, Q. (2007) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20060114 · Cited by 22
Patten, D. A., & Shetty, S. (2019) · Biomolecules · doi:10.3390/biom9070283 · Cited by 23
Three’s Company: Two or More Unrelated Receptors Pair with the Same Ligand
Ben‐Shlomo, I., & Hsueh, A. J. W. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0451 · Cited by 21
Zhang, P., Cui, W., Hankey, K. G., Gibbs, A. M., Smith, C. P., Taylor-Howell, C., Kearney, S. R., & MacVittie, T. J. (2015) · Health Physics · doi:10.1097/hp.0000000000000343 · Cited by 20
Shun, C., Lin, S., Hong, C., Huang, H., & Liu, C. (2011) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2011.25.3557 · Cited by 20
Hypoxia-Induced Cyr61/CCN1 Production in Infantile Hemangioma
Wu, P., Xu, H., Li, N., Huo, R., Shen, B., Lin, X., & Ma, G. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000007672 · Cited by 19
Plasminogen on the surfaces of fibrin clots prevents adhesion of leukocytes and platelets
Lishko, V. K., Yermolenko, I. S., & Ugarova, T. P. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03778.x · Cited by 19
Self-citationRU486 Metabolite Inhibits CCN1/Cyr61 Secretion by MDA-MB-231-Endothelial Adhesion
Yu, S., Yan, C., Wu, W., He, S., Liu, M., Liu, J., Yang, X., Ma, J., Lu, Y., & Jia, L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01296 · Cited by 19
The Opioid Peptide Dynorphin a Induces Leukocyte Responses via Integrin Mac-1 (αMβ2, CD11b/CD18)
Podolnikova, N. P., Brothwell, J. A., & Ugarova, T. P. (2015) · Molecular Pain · doi:10.1186/s12990-015-0027-0 · Cited by 19
Self-citationEbnerasuly, F., Hajebrahimi, Z., Tabaie, S. M., & Darbouy, M. (2017) · Iranian Journal of Biotechnology · doi:10.15171/ijb.1747 · Cited by 19
Huang, Z., Wang, H., & Ji, Z. (2021) · Inflammation Research · doi:10.1007/s00011-021-01494-7 · Cited by 19
Mahendiran, T., Klingenberg, R., Nanchen, D., Gencer, B., Meier, D. J., Räber, L., Carballo, D., Matter, C. M., Lüscher, T. F., Mach, F., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.09.019 · Cited by 16
The matricellular protein CCN1 regulates TNF‐α induced vascular endothelial cell apoptosis
Zhang, J. C., Wu, G., & Dai, H. (2015) · Cell Biology International · doi:10.1002/cbin.10469 · Cited by 17
Evaluation of Serum Cysteine-Rich Protein 61 levels in Patients with Coronary Artery Disease
Deng, J., Qian, X., Li, J., Li, Y., Li, Y., & Luo, Y. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0390 · Cited by 17
Novel Functions of Integrins as Receptors of CD154: Their Role in Inflammation and Apoptosis
Hassan, G. S., Salti, S., & Mourad, W. M. (2022) · Cells · doi:10.3390/cells11111747 · Cited by 17
Hviid, C. V. B., Erdem, J. S., Kunke, D., Ahmed, S. M., Kjeldsen, S. F., Wang, Y. Y., Attramadal, H., & Aasen, A. O. (2012) · Innate Immunity · doi:10.1177/1753425912436764 · Cited by 17
Smad3-dependent CCN2 mediates fibronectin expression in human skin dermal fibroblasts
Purohit, T., Qin, Z., Quan, C., Lin, Z., & Quan, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173191 · Cited by 20
Kubota, S., Mukudai, Y., Moritani, N. H., Nakao, K., Kawata, K., & MasaharuTakigawa (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.05.068 · Cited by 17
Lin, J. B., Santeford, A. C., Colasanti, J. J., Lee, Y., Shah, A. V., Wang, T. J., Ruzycki, P. A., & Apte, R. S. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101353 · Cited by 17
Zhou, J., Sun, X., Yang, L., Wang, L., Ran, G., Wang, J., Cao, Q., Wu, L., Bryant, A., Ling, C., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902382r · Cited by 16
Therapeutic potential of cysteine-rich protein 61 in rheumatoid arthritis
Xu, T., He, Y., Wang, M., Yao, H.-W., Ni, M.-M., Zhang, L., Meng, X., Huang, C., Ge, Y., & Li, J. (2016) · Gene · doi:10.1016/j.gene.2016.07.053 · Cited by 16
Hviid, C. V. B., Samulin Erdem, J., Drechsler, S., Weixelbaumer, K., Ahmed, M. S., Attramadal, H., Redl, H., Bahrami, S., Osuchowski, M. F., & Aasen, A. O. (2014) · Shock · doi:10.1097/shk.0000000000000105 · Cited by 15
Association of serum Cyr61 levels with peripheral arterial disease in subjects with type 2 diabetes
Feng, B., Xu, G., Sun, K., Duan, K., Shi, B., & Zhang, N. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01171-9 · Cited by 15
Cyr61 promotes Schwann cell proliferation and migration via αvβ3 integrin
Cheng, Z., Zhang, Y., Tian, Y., Chen, Y., Ding, F., Wu, H. J., Ji, Y., & Shen, M. (2021) · BMC Molecular and Cell Biology · doi:10.1186/s12860-021-00360-y · Cited by 15
Shi, Y., Tu, Z., Wang, W., Li, Q., Ye, F., Wang, J., Qiu, J., Zhang, L., Bu, H., & Li, Y. (2006) · Cytokine · doi:10.1016/j.cyto.2006.10.009 · Cited by 15
Biomarkers in Acute and Chronic Kidney Diseases
Sabbisetti, V. S., & Bonventre, J. V. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10029-6 · Cited by 14
CCN1 Induces β -Catenin Translocation in Esophageal Squamous Cell Carcinoma through Integrin α 11
Chai, J., Modak, C., Ouyang, Y. Q., Wu, S.-Y., & Jamal, M. M. (2012) · ISRN Gastroenterology · doi:10.5402/2012/207235 · Cited by 14
Sakamoto, S., Yokoyama, M., Kulkarni, P., Tsuruha, J.-I., Masamoto, S., Getzenberg, R. H., & Kakehi, Y. (2003) · SLAS DISCOVERY · doi:10.1177/1087057103259159 · Cited by 14
CYR61 as a Potential Biomarker and Target in Cancer Prognosis and Therapies
Schenker, A. J., & Ortiz-Hernández, G. L. (2025) · Cells · doi:10.3390/cells14110761 · Cited by 13
Sprangers, S., Schoenmaker, T., Cao, Y., Everts, V. E., & de Vries, T. J. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.11.018 · Cited by 13
The regulation and functions of the matricellular CCN proteins induced by shear stress
Wang, Y.-K., Weng, H.-K., & Mo, F. (2023) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-023-00760-z · Cited by 12
The Role of CCN1 in Esophageal Adenocarcinoma: What We Have Learned From the Lab
Chang, Z., Dang, T., Meng, X., & Chai, J. (2022) · Cancer Control · doi:10.1177/10732748221074734 · Cited by 12
Jiang, J., Leong, N. L., Khalique, U., Phan, T. M., Lyons, K., & Luck, J. V. (2016) · Haemophilia · doi:10.1111/hae.13049 · Cited by 11
Mo, F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.640781 · Cited by 11
Sheng-Ji Hua-Yu Ointment Ameliorates Cutaneous Wound Healing in Diabetes Via Up-Regulating CCN1
Yang, D., Tan, Y.-M., Zhang, Y., Song, J., Luo, Y., Luo, Y., Fei, X., Ru, Y., Li, B., Jiang, J., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115954 · Cited by 10
Luo, C., Zhu, Y., Zhou, J., Sun, X., Zhang, S., Tan, S., Li, Z., Lin, H. P., & Zhang, W. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109235 · Cited by 10
Cao, Z., Yu, W., Li, W., Fan, C., Xia, Y., Rao, T., Yao, X., Zhang, X., & Larré, S. (2013) · Urology · doi:10.1016/j.urology.2013.08.024 · Cited by 10
Metadata
- Authors
- Schober, J. M., Chen, N., Grzeszkiewicz, T. M., Jovanovic, I., Emeson, E. E., Ugarova, T. P., Ye, R. D., Lau, L. F., & Lam, S. C.-T.
- Affiliations
- Cleveland Clinic (US)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-06-15
- Volume
- 99
- Issue
- 12
- Pages
- 4457-4465
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2048563910
- Cited by
- 242
- References
- 54
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 6 · 2021: 15 · 2020: 8 · 2019: 12 · 2018: 8 · 2017: 11 · 2016: 14 · 2015: 9 · 2014: 8 · 2013: 11 · 2012: 10
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca080080-05)
- National Heart, Lung, and Blood Institute (HL07829, HL41793, HL 63199, R01HL063199)
- National Cancer Institute (CA-80080, R01CA046565, CA-46565)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- Mac-1, CYR61, connective tissue growth factor, monocyte adhesion, monocyte transmigration, atherosclerosis, heparan sulfate proteoglycans, ApoE-deficient mice, THP-1 cells, integrin I domain, cell adhesion, wound healing
- MeSH terms
- Animals, Apolipoproteins E, Arteriosclerosis, Cell Adhesion, Disease Models, Animal, Growth Substances, Humans, Immunohistochemistry, Monocytes, Protein Binding, Integrins, Macrophage-1 Antigen, Protein Structure, Tertiary, Immediate-Early Proteins, Mice, Knockout, Intercellular Signaling Peptides and Proteins, Mice, Connective Tissue Growth Factor, Cysteine-Rich Protein 61
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review